Light-dark variations in neopterin serum levels in patients with ST-segment elevation acute coronary syndrome undergoing primary angioplasty;Variaciones luz/oscuridad de las concentraciones séricas de neopterina en pacientes con síndrome coronario agudo con elevación del segmento ST tratados con angioplastia primaria

Revista Espanola de Cardiologia

Volumn 61, Issue 12, 2008, Pages 1280-1286

  García González, Martín J ^a   Domínguez Rodríguez, Alberto ^a   Abreu González, Pedro ^b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Acute coronary syndrome; Light dark variations; Neopterin

Indexed keywords

NEOPTERIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOPLASTY; ARTICLE; CARDIAC PATIENT; CELLULAR IMMUNITY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; LIGHT DARK CYCLE; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION;

EID: 57349136369     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/s0300-8932(08)75736-1     Document Type: Article

References (39)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-26.
2. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol. 1997;29:419-23.
3. Kervinen H, Manttari M, Kaartinen M, Makynen H, Palosuo T, Pulkki K, et al. Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes. Am J Cardiol. 2004;94:993-6.
4. Auerbach G, Nar H. The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydroxilase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem. 1997;378:185-92.
5. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984;160:310-6.
6. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3:175-87.
7. Schumacher M, Halwachs G, Tatzber F, Fruhwald FM, Zweiker R, Watzinger N, et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol. 1997;30:703-7.
8. Gurfinkel EP, Scirica BM, Bozovich G, Macchia A, Manos E, Mautner B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol. 1999;83:515-8.
9. Tanaka T, Nakamura Y, Nasuno A, Mezaki T, Higuchi K, Fukunaga H, et al. Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Association with the severity of coronary atherosclerosis. Circ J. 2004;68:114-20.
10. Garcia-Moll X, Coccolo F, Cole D, Kaski JC. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol. 2000;35:956-62.
11. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Aldama G, Pizzi C, Quiles J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart. 2004;90:847-52.
12. Kaski JC, Avanzas P, Arroyo-Espliguero R. Neopterin: still a forgotten biomarker. Clin Chem 2005;51:1902-3.
13. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frecuency of onset of acute myocardial infarction. The MILLIS Study Group. N Engl J Med. 1985;313:1315-22.
14. Abo T, Kawate K, Itoh K, Kumagai K. Studies on the bioperiodicity of the immune response. Circadian rhythms of human T, B and K cell traffic in the peripheral blood. J Immunol. 1981;126:1360-6.
15. Libby P. Current concepts of the pathogenesis of acute coronary syndromes. Circulation. 2001;104:365-9.
16. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes Circulation. 2000;101:2883-8.
17. Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol. 2005;45:1939-45.
18. Auer J, Berent R, Labetanig E, Erb B. Serum neopterin and activity of coronary artery disease. Heart Dis. 2001;3:297-301.
19. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation. 2004;110:1747-53.
20. Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, et al. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation. 2007;115:3071-8.
21. Hernandes Fernandes E, Coelho D, Missel Correa JR, Kumpinski D. Alteraciones circadianas del sistema cardiovascular. Rev Esp Cardiol. 2000;53:117-22.
22. Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P. Link between arterial inflammation and circadian rhythm: the oversight aspect in the year 2004. J Am Coll Cardiol. 2006;47:688-9.
23. Tofler GH, Muller JE. Triggering of acute cardiovascular disease and potential preventive strategies. Circulation. 2006;114:1863-72.
24. Tanaka A, Kawarabayashi T, Fukuda D, Nishibori Y, Sakamoto T, Nishida Y, et al. Circadian variation of plaque rupture in acute myocardial infarction. Am J Cardiol. 2004;93:1-5.
25. Jankovic BD. Neuroimmunomodulation. From phenomenology to molecular evidence. Ann N Y Acad Sci. 1994;741:1-38.
26. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev. 1991;12:151-80.
27. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol. 1997;158:4454-64.
28. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol. 1998;16:635-49.
29. Domínguez Rodríguez A, Abreu González P, García MJ, De la Rosa A, Vargas M, Marrero F. Ritmo luz/oscuridad de las citocinas proinflamatorias en el infarto agudo de miocardio. Rev Esp Cardiol. 2003;56:555-60.
30. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, Ferrer J, De la Rosa A, Vargas M, et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine. 2004;26:89-93.
31. Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P, Ferrer J, Kaski JC. Relation of nocturnal melatonin levels to Creactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2006;97:10-2.
32. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Reiter RJ. Relation of nocturnal melatonin levels to serum matrix metallopriteinase-9 concentrations in patients with myocardial infarction. Thromb Res. 2007;120:361-6.
33. Auzéby A, Bogdan A, Krosi Z, Touitou Y. Time-dependence of urinary neopterin, a marker of cellular immune activity. Clin Chem. 1988;34:1866-7.
34. García González MJ, Domínguez Rodríguez A, Abreu González P. Diurnal variations in serum neopterin levels are associated with the pineal hormone melatonin circadian rhythm in healthy human subjects. J Pineal Res. 2006;40:288-9.
35. Levi FA, Canon C, Touitou Y, Sulon J, Mechkouri M, Ponsart ED, et al. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men. Clin Exp Immunol. 1988;71:329-35.
36. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation. 2007;115:996-1003.
37. Christian S, Lampe A, Rumpold G, Geser W, Noisternig B, Chamson E, et al. The influence of daily psychosocial stressors and associated emotions on the dynamic course of urine cortisol and urine neopterin in systemic lupus erythematosus: Experience taken from two "integrative single-case studies". Z Psychosom Med Psychother. 2001;47:58-79.
38. Schubert C, Lampe A, Geser W, Noisternig B, Fuchs D, König P, et al. Daily psychosocial stressors and cyclic response patterns in urine cortisol and neopterin in a patient with systemic lupus erythematosus. Psychoneuroendocrinology. 2003;28:459-73.
39. Fyfe A, Daly P, Galligan L, Pirc L, Feindel C, Cardella C. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft. J Am Coll Cardiol. 1993;21:171-6.